| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| translarna fda approval letter | 1.12 | 0.5 | 8935 | 34 | 30 |
| translarna | 1.08 | 0.1 | 166 | 84 | 10 |
| fda | 0.06 | 0.1 | 3954 | 24 | 3 |
| approval | 1.63 | 0.2 | 5532 | 17 | 8 |
| letter | 0.71 | 0.4 | 2766 | 71 | 6 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| translarna fda approval letter | 0.73 | 0.1 | 8137 | 62 |
| translarna fda approval implications | 1.63 | 0.4 | 5719 | 32 |
| translarna fda approval history | 0.75 | 0.5 | 2754 | 87 |
| translarna fda approval criteria | 0.7 | 0.9 | 2535 | 47 |
| translarna fda approval date | 1.22 | 0.8 | 5473 | 61 |
| translarna fda approval 2020 | 0.78 | 0.3 | 7734 | 60 |
| translarna fda approval prospects | 1.39 | 0.5 | 53 | 12 |
| translarna fda approval 2021 | 0.1 | 0.6 | 2621 | 31 |
| translarna fda approval timeline | 0.48 | 0.9 | 4266 | 42 |
| translarna fda approval challenges | 1.66 | 0.2 | 8555 | 41 |
| translarna fda approval for cf | 1.77 | 0.7 | 8328 | 15 |
| translarna fda approval for sma | 1.41 | 0.3 | 2191 | 13 |
| translarna fda approval for rare diseases | 1.79 | 0.7 | 1168 | 2 |
| translarna fda approval for nm | 1.4 | 0.4 | 5969 | 3 |
| translarna fda approval for dmd | 1.16 | 0.5 | 7125 | 40 |
| translarna fda briefing document | 0.71 | 0.3 | 207 | 23 |
| translarna fda advisory committee | 0.9 | 0.9 | 731 | 12 |
| translarna mechanism of approval | 0.35 | 0.7 | 7878 | 72 |
| translarna buy from authorized dealer | 0.26 | 0.1 | 4649 | 20 |
| translarna buy in usa | 0.63 | 0.2 | 4221 | 33 |
